AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. We invest in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology, cardio vascular and metabolic diseases and respiratory diseases.

Our science benefits from a combination of in-house capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by strong translational science and personalised healthcare capabilities. We also collaborate with world-renowned scientists and academic institutions and partner with like-minded science-led companies.